香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 Kingland Group Holdings Limited 景聯集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1751） 自願性公告 收購目標公司全部股權及 完成工商變更登記 本 公 告 乃 由 景 聯 集 團 控 股 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本集團」） 自 願 作 出，以 使 本 公 司 股 東 及 潛 在 投 資 者 了 解 本 集 團 的 最 新 業 務 發 展。 本 公 司 董 事（「董 事」）會（「董事會」）欣 然 宣 佈，於 本 公 告 日 期 前，本 集 團 收 購 廣 東 楓 鑫 水 利 水 電 工 程 有 限 公 司（以 下 簡 稱「廣東楓鑫」或「目標公司」）100%股 權，廣 東 楓 鑫 為 一 家 於 中 華 人 民 共 和 國（「中 國」）註 冊 成 立 的 有 ...

Core Insights - Johnson & Johnson (JNJ) is focusing on expanding its pharmaceutical portfolio through potential acquisition opportunities, specifically Protagonist Therapeutics [2][6] - The company is set to report strong third-quarter earnings, with expected earnings of $2.76 per share and revenue of $23.76 billion, indicating growth from the previous year [3][6] - The FDA has approved JNJ's Simponi for children with ulcerative colitis, which has positively impacted the stock price and reflects the company's commitment to addressing unmet medical needs [4][6] Stock Performance - As of the latest trading, JNJ is priced at $191.29, showing a slight increase of 0.21, with a market capitalization of approximately $460.69 billion [5] - The stock has experienced fluctuations between a low of $190.31 and a high of $192.06 on the trading day, with a yearly high of $192.1 and a low of $140.68 [5] Analyst Insights - RBC Capital has set a new price target for JNJ at $209, suggesting a potential increase of approximately 9.26% from the current trading price [1][6]

Core Viewpoint - The company, Jingwei Huirun (300120), announced on September 12 that it plans to enter projects aligned with its strategic planning, including radio frequency, through investments and acquisitions [1] Group 1 - The company is actively seeking to expand its business into the radio frequency sector [1] - Future announcements regarding this strategic move will be made by the company [1]

Group 1 - The core point of the article is that Xiamen Xindian Network Group Co., Ltd. announced the establishment of four wholly-owned subsidiaries to expand its business scope and seek new growth opportunities [1][1][1] Group 2 - The four new subsidiaries are Xiamen Deep Wisdom Manufacturing Co., Ltd., Xiamen Intelligent Creation Manufacturing Co., Ltd., Xiamen Turing Manufacturing Co., Ltd., and Deep Wisdom (Xiamen) Electronic Technology Co., Ltd., each with a registered capital of RMB 10 million [1][1][1] - The establishment of these subsidiaries is part of the company's strategic development needs, aimed at better resource allocation and business expansion [1][1][1]